Universal Time: 03:55  |  Local Time: 03:55 (3h GMT)
Select your timezone:

Mini-Oral Abstract Session
Immunosuppression and Tolerance 2

|
Room: Auditorium
Track: N/A

Presentations

Dr. Hidetaka Hara, People's Republic of China
Moderator

Dr. Anjali Verma, United States
Ex vivo pig liver xenoperfusion with human red blood cells and mesenchymal stem cells to enhance the endothelial barrier function and attenuate inflammation

Dr. Huan Wang, People's Republic of China
Application of immunosuppressive regimen in xenotransplantation of gene-edited porcine heart to rhesus macaque

Yi Wang, People's Republic of China
Gut microbiota metabolite L-Histidine (L-His) alleviates tacrolimus-induced islet dysfunction post-transplantation via IRS-2/Akt/mTOR/FOXO1 signaling pathway

Viktoriia Galdina, Switzerland
Generation and functional assessment of human cytotoxic T cells directed against wild-type and genetically modified pig endothelial cells

Dr. Man Zhang, People's Republic of China
Immortalized aortic endothelial cells from genetically modified pigs for evaluation of human‑to‑pig xenoreactive immune responses

Ms. Yunxia (Erica) Xu, People's Republic of China
KJ047 is a next generation CD40 ligand antibody designed for safe and durable immunosuppression in combination with IgG degrading enzymes

Dr. Sho Fujiwara, United States
Early mixed chimerism after pig to non-human primate liver xenotransplantation

© 2025 IXA 2025